In this Issue:
•Will the Other Shoe Drop?: Companies are taking the knife to medical benefits, and they're not just trimming the fat.
•In the Limelight
•STARS Status: Changes in S&P analysts' STARS rankings for March 13 through March 17.
•Three Recent Upgrades: S&P equity analysts expect these stocks to outperform the market over the coming 12 months.
•Our Analysts' Reading on Utilities
•Biotechnology's Promising Pipeline: We believe there will be more biotech drug approvals this year than last. Here's a look at which firms we think stand to benefit and our stock picks in the group.
•Powerwave Makes Waves; Andrew Corp. Gets Wet: In this side-by-side comparison, we explain why we favor one of these wireless communications equipment providers over the other.
•FPL's Future Looks Bright: We like this utility on its own merits, and think a proposed acquisition would create an even more profitable enterprise.
•Harness Our Quant Power: Standard & Poor's Neural Fair Value 25 Portfolio buys what are deemed undervalued issues with superior return potential.

Some of the Companies Featured:
American Reprographics Co.
Andrew Corp.
Goldman Sachs
Marsh & Mclennan
Patterson Cos.
Powerwave Technologies Inc.
Ross Stores
Semtech Corp.
WPP Group Plc

S&P Information Products

Browse S&P industry research products by category:

S&P Industry Surveys
S&P Industry Stock Reports
The Outlook
Search Engine Survey
Pocket Guides
Power Picks

About Standard & Poor's

Standard & Poor's is one of the world's preeminent providers of credit ratings, and for such globally recognized financial-market indices as the S&P 500®. S&P also provides a wide range of other products and services designed to help individuals and institutions around the world make better-informed financial decisions with greater confidence.